EcoDrugPlus

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSMZEG00005010556
Gene Symbol: MST1R
2 Cross references
193 Possible Orthologues:

Macrophage-Stimulating Protein Receptor

Ensembl ID : ENSMZEG00005015221
Gene Symbol: LOC101469724
2 Cross references
188 Possible Orthologues:

Mast Cell Protease 1a

Ensembl ID : ENSMZEG00005010236
Gene Symbol: LOC101464713
2 Cross references
949 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita

Ensembl ID : ENSMZEG00005023827
Gene Symbol: LOC101477603
3 Cross references
200 Possible Orthologues:

Mastermind-Like Domain-Containing Protein 1

Ensembl ID : ENSMZEG00005006286
Gene Symbol: LOC101487929
2 Cross references
190 Possible Orthologues:

Matrilysin-Like

Ensembl ID : ENSMZEG00005013568
Gene Symbol: LOC101486079
2 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSMZEG00005006880
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSMZEG00005006471
Gene Symbol: MMP9
3 Cross references
214 Possible Orthologues:

Matrix Metalloproteinase-14

Ensembl ID : ENSMZEG00005020950
Gene Symbol: LOC101486213
3 Cross references
198 Possible Orthologues:

Matrix Metalloproteinase-14

Ensembl ID : ENSMZEG00005012114
Gene Symbol: LOC101464934
3 Cross references
196 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSMZEG00005004720
Gene Symbol: MTOR
3 Cross references
216 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSMZEG00005012573
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).